MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
RCUS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Arcus Biosciences (RCUS) Ownership - Who owns Arcus Biosciences?

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.12B
P/E Ratio
N/A
Total Cash
911M
Projected Growth
N/A
Total Debt
109M
Revenue
262M
Risk (Beta)
1.52
Dividend Yield
N/A
Total Cash/Share
8.56
Total Debt/Equity
N/A
Revenue/Share
2.70 USD as % of share price

Fundamentals

RCUS
Capitalization
1.12B
P/E Ratio
N/A
Risk (Beta)
1.52
Dividend Yield
N/A
Total Cash
911M
Total Cash/Share
8.56
Total Debt
109M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.70%
Revenue
262M
ROE
N/A
Book Value
549M
P/B Ratio
2.04
Cash Flow
N/A
Earnings
-3.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.79B
Current Ratio
4.50
Current Revenue Per Employee
237388.72
Dividends Per Share - Security
N/A
EBITDA
-282M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-26.36
Shares Held By Institutions
797M
Shares Outstanding - Current
106M
Total Liabilities
526M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-29.281
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RCUS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For RCUS
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RCUS showed earnings on August 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com